Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors
Clinical trial NCT02688881 · COMPLETED
Trial details
- NCT number
- NCT02688881
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-05
- Primary completion
- 2020-12-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.